Press release
Dysmenorrhea Treatment Market Growth - Global Industry In Depth Study And Huge Demand In Future 2022-2030
Dysmenorrhea Treatment Market
In a recent research report by Market Research Community, the dysmenorrhea treatment market is expected to surpass USD XX billion by the year 2030, from USD XX billion in 2021.
Menstrual cramps are severe cramps that start in the lower abdomen and spread to the back, this, and legs. Several women begin experiencing severe pain during early puberty, about five years after the start of their menstrual cycle medically called dysmenorrhea. The treatment used in dysmenorrhea is known as dysmenorrhea treatment.
Request Sample Report @ https://marketresearchcommunity.com/sample-request/?rid=685
The global prevalence of disorders such as endometriosis, the primary cause of secondary dysmenorrhea, is increasing. Endometriosis affects an estimated 1 in 10 women throughout their fertile years, or around 176 million people globally, according to an article titled "Understanding Endometriosis-the Basics" published in July 2021. This element is predicted to have a substantial influence on market growth. As a result of the aforementioned factors, the nonsteroidal anti-inflammatory medicine category is predicted to considerably contribute to market expansion.
Top Key Players of the Dysmenorrhea Treatment Market:
Novartis AG, Bayer AG, Abbott Laboratories, F. Hoffmann-La Roche Ltd, Sanofi, Pfizer Inc., GlaxoSmithKline PLC, Focus Consumer Healthcare, Johnson & Johnson, and Alvogen.
North America is dominate the growth of the dysmenorrhea treatment market owing to the introduction of innovative products for treating the discomfort associated with primary and secondary dysmenorrhea.
For example, in 2021, Pfizer Inc. and Myovant Sciences received FDA authorization for the assessment of a supplementary Novel Drug Application (sNDA) for MYFEMBREE (relugolix 40 mg, estradiol 1 mg, and norethindrone acetate 0.5 mg) to treat mild to severe endometriosis pain. As a result of these reasons, the market for dysmenorrhea therapy in the United States is predicted to increase considerably over the forthcoming years.
Check Discount on Dysmenorrhea Treatment Market @ https://marketresearchcommunity.com/request-discount/?rid=685
The market is projected to grow at a significant pace reaching a CAGR of approximately 8.3%, over the forecast period of 2022-2030, despite a considerable fall in product sales during the initial phase of pandemic spread and lockdown restrictions imposed globally.
Type Covered in This Report Are:
Primary Dysmenorrhea
Secondary Dysmenorrhea
Regional Analysis:
North America- (U.S., Canada, Mexico)
Europe- (Germany, France, U.K., Russia, Italy, Spain, BENELUX, Rest of Europe)
Asia Pacific- (China, Japan, India, South Korea, Australia, ASEAN, Rest of Asia Pacific)
Latin America- (Brazil, Argentina, Chile, Rest of Latin America)
Middle East and Africa- (GCC, Turkey, Israel, Rest of MEA)
Get Full Report @ https://marketresearchcommunity.com/dysmenorrhea-treatment-market/
The study is consolidated into major segments and further into sub-segments, such as by Type (Primary Dysmenorrhea, Secondary Dysmenorrhea), by Treatment Type (Non-steroidal Anti-inflammatory Drugs (NSAIDs), Hormonal Therapy) to forecast the market size by value; also includes the analysis of past market dynamics from 2016 - 2021, considering 2021 as the base year.
Our Recently Published Reports:
https://marketresearchcommunity.com/wound-dressings-market/
https://marketresearchcommunity.com/digital-variable-gain-amplifier-market/
https://marketresearchcommunity.com/teleradiology-services-market/
https://marketresearchcommunity.com/global-commercial-greenhouse-market/
https://marketresearchcommunity.com/europe-asia-and-north-america-long-fiber-thermoplastics-lft-market/
https://marketresearchcommunity.com/molecular-diagnostics-market/
Contact:
Market Research Community
+44-20-8133-9198
sales@marketresearchcommunity.com
Market Research Community is the leading research industry that offers contextual and data-centric research services to its customers across the globe. The firm assists its clients to strategize business policies and accomplish sustainable growth in their respective market domain. The industry provides consulting services, syndicated research reports, and customized research reports.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Dysmenorrhea Treatment Market Growth - Global Industry In Depth Study And Huge Demand In Future 2022-2030 here
News-ID: 2742003 • Views: …
More Releases for Dysmenorrhea
Dysmenorrhea Market Share, Epidemiology, Analysis & Trends 2023-2033
Market Overview:
The dysmenorrhea market is expected to exhibit a CAGR of 5.67% during 2023-2033. The dysmenorrhea market report offers a comprehensive analysis of the market in the United States, EU5 (including Germany, Spain, Italy, France, and the United Kingdom), and Japan. It covers aspects such as treatment methods, drugs available in the market, drugs in development, the market share of various therapies, and the market's performance in the seven major…
Dysmenorrhea - Drug Pipeline Landscape, 2022
Global Dysmenorrhea Market report from Global Insight Services is the single authoritative source of intelligence on Dysmenorrhea market. The report will provide you with analysis of impact of latest market disruptions such as Russia-Ukraine war and Covid-19 on the market. Report provides qualitative analysis of the market using various frameworks such as Porters' and PESTLE analysis. Report includes in-depth segmentation and market size data by categories, product types, applications, and…
Dysmenorrhea - Drug Pipeline Landscape, 2022
Dysmenorrhea, also known as painful periods or menstrual cramps, is a common problem experienced by women during their reproductive years. It is estimated that 50-90% of women of reproductive age suffer from dysmenorrhea. The pain is usually felt in the lower abdomen and can range from mild to severe. The pain may begin one to two days before the start of menstru*tion and last for the first few days of…
Dysmenorrhea - Drug Pipeline Landscape, 2022
Dysmenorrhea, also known as painful periods or menstrual cramps, is a common problem experienced by women during their reproductive years. It is estimated that 50-90% of women of reproductive age suffer from dysmenorrhea. The pain is usually felt in the lower abdomen and can range from mild to severe. The pain may begin one to two days before the start of and last for the first few days of…
Dysmenorrhea Treatment Market: Market Intelligence and Market Trends
Dysmenorrhea is a medical terminology used for menstrual pains in which the female encounters severe cramps in her lower abdomen which may extend to the lower legs and back. Most women begin having dysmenorrhea during adolescence, usually within four to five years of first menstrual period. Prostaglandins are chemicals that are formed in the lining of the uterus during menstruation. These prostaglandins cause muscle contractions in the uterus, which cause…
Dysmenorrhea Treatment Market size and forecast, 2016-2026
Dysmenorrhea is a medical terminology used for menstrual pains in which the female encounters severe cramps in her lower abdomen which may extend to the lower legs and back. Most women begin having dysmenorrhea during adolescence, usually within four to five years of first menstrual period. Prostaglandins are chemicals that are formed in the lining of the uterus during menstruation. These prostaglandins cause muscle contractions in the uterus, which cause…
